Literature DB >> 11920409

Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis.

Masato Yamada1, Hideo Yagita, Hideko Inoue, Tsuyoshi Takanashi, Hironori Matsuda, Eiko Munechika, Yutaka Kanamaru, Isao Shirato, Yasuhiko Tomino, Kouji Matushima, Ko Okumura, Hiroshi Hashimoto.   

Abstract

OBJECTIVE: Some chemokine receptors, such as CCR5 and CCR4, are differentially expressed on Th1 and Th2 cells. To determine whether differential expression of the chemokine receptors occurs in patients with lupus nephritis, we examined the expression of CCR4 and CCR5 on peripheral blood lymphocytes and mononuclear cells infiltrated into the renal tissue of patients with lupus nephritis.
METHODS: The expression of CCR4 and CCR5 on CD4+,CD45RO+ cells was analyzed by flow cytometry and compared between patients with systemic lupus erythematosus (SLE) and healthy controls. Correlation between the absolute number of CCR4+ or CCR5+ cells and clinical parameters was also analyzed. Mononuclear infiltrates in the renal tissue of SLE patients were analyzed for the expression of CCR4, CCR5, and CD4 by immunohistochemical staining.
RESULTS: The absolute number of CCR4+, but not CCR5+, T lymphocytes in the peripheral blood was significantly decreased in the patients with SLE compared with that in the healthy controls, and this positively correlated with the serum levels of C3 and CH50. Most of the CD4+ T lymphocytes that infiltrated into the renal tissue of the patients with lupus nephritis expressed CCR4, but not CCR5.
CONCLUSION: These results suggest that CCR4+ T lymphocytes in peripheral blood, which represent Th2 cells, preferentially migrate into the renal tissue of patients with lupus nephritis. The maldistribution of CCR4+ T lymphocytes might be involved in the pathogenesis of lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920409     DOI: 10.1002/art.10112

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  17 in total

1.  Drugs, sun and T cells in lupus.

Authors:  G C Tsokos
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

2.  The pentapeptide PLNPK inhibits systemic lupus erythematosus-associated renal damage.

Authors:  Jun-qiang Lv; Wen Zhang; Song Wang; Lin Zhao; Rui Ma; Jin-wei Hu; Li-juan Wang; Jie Meng; Chun-lei Zhou; Gang Lin; Rong Lu; Zhi Yao
Journal:  Inflamm Res       Date:  2010-07-01       Impact factor: 4.575

3.  T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells.

Authors:  Jiankun Zhu; Xuebin Liu; Chun Xie; Mei Yan; Ying Yu; Eric S Sobel; Edward K Wakeland; Chandra Mohan
Journal:  J Clin Invest       Date:  2005-06-09       Impact factor: 14.808

4.  CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients.

Authors:  Thiago Hissnauer Leal Baltus; Ana Paula Kallaur; Marcell Alysson Batisti Lozovoy; Helena Kaminami Morimoto; Francieli Delongui; Daniela Frizon Alfieri; Tatiane Mayumi Veiga Iriyoda; Isaias Dichi; Andrea Name Colado Simão; Edna Maria Vissoci Reiche
Journal:  Rheumatol Int       Date:  2015-06-14       Impact factor: 2.631

5.  Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus.

Authors:  P T Yang; H Kasai; L J Zhao; W G Xiao; F Tanabe; M Ito
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

6.  The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus.

Authors:  Wenpu Zhao; Seth G Thacker; Jeffrey B Hodgin; Hongyu Zhang; Jeffrey H Wang; James L Park; Ann Randolph; Emily C Somers; Subramaniam Pennathur; Matthias Kretzler; Frank C Brosius; Mariana J Kaplan
Journal:  J Immunol       Date:  2009-07-20       Impact factor: 5.422

7.  Aberration of CCR7 CD8 memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4 T cells.

Authors:  Yang Sen; Hu Chunsong; Huang Baojun; Zhang Linjie; Li Qun; Jiang San; Zhang Qiuping; Liu Junyan; Xuejun Zhang; Tan Jinquan
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

8.  CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus.

Authors:  M Mamtani; B Rovin; R Brey; J F Camargo; H Kulkarni; M Herrera; P Correa; S Holliday; J-M Anaya; S K Ahuja
Journal:  Ann Rheum Dis       Date:  2007-10-30       Impact factor: 19.103

9.  Lupus nephritis: an overview of recent findings.

Authors:  Alberto de Zubiria Salgado; Catalina Herrera-Diaz
Journal:  Autoimmune Dis       Date:  2012-03-22

10.  Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis.

Authors:  Sebastian Dolff; Wayel H Abdulahad; Suzanne Arends; Marcory C R F van Dijk; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Journal:  Arthritis Res Ther       Date:  2013-02-27       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.